Comparing measurement properties of EQ-5D and SF-6D in East and South-East Asian populations: a scoping review-Reference-Cited by-同舟云学术

Comparing measurement properties of EQ-5D and SF-6D in East and South-East Asian populations: a scoping review

Published:2023-03-15 Issue:5 Volume:23 Page:449-468
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Zhang Aixue¹²,Mao Zhuxin³,Wang Zitong¹,Wu Jing⁴,Luo Nan⁵,Wang Pei¹²

Affiliation:

1. School of Public Health, Fudan University, Shanghai, Hong Kong, China

2. KeyLaboratory of Health Technology Assessment, National Health Commission of the People’s Republic of China (Fudan University), Shanghai, Hong Kong, China

3. Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), University of Antwerp, Antwerp, Belgium

4. School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, Beijing, China

5. Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2023.2189590

Reference65 articles.

1. Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines

2. Measurement Properties of Commonly Used Generic Preference-Based Measures in East and South-East Asia: A Systematic Review

3. EuroQol: the current state of play

4. Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension

5. Exploring the consistency of the SF-6Dv2 in a breast cancer population

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychometric performance of EQ-5D-5L and SF-6Dv2 in patients with lymphoma in China;The European Journal of Health Economics;2024-03-07

2. Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary;PharmacoEconomics;2024-02-28